Literature DB >> 11201848

Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake.

S Benvenga1, M Lakshmanan, F Trimarchi.   

Abstract

Carnitine (3-hydroxy-4N-trimethylammoniumbutanoate) is a naturally occurring quaternary amine that is ubiquitous in mammalian tissues (concentrations in the order of mM). Based on limited studies of approximately 40 years ago, carnitine was considered to be a peripheral antagonist of thyroid hormone (TH) action. These interesting observations have not been explored. To study the biologic basis of this effect, we tested the following possibilities in three TH-responsive cell lines: (1) inhibition of TH entry into cells; (2) inhibition of TH entry into the nucleus; (3) inhibition of TH interaction with the isolated nuclei; and (4) facilitated efflux of TH from cells. On a preliminary basis we had verified that these cell lines (human skin fibroblasts, human hepatoma cells HepG2, and mouse neuroblastoma cells NB 41A3) take up 14Ccarnitine; however, there was no 14Ccarnitine uptake into the nuclei. Concentrations of unlabeled carnitine as high as 100 mM did not affect (125I)T3 binding to isolated nuclei or exit of TH from cells, thus excluding possibilities numbered 3 and 4. At 10 mM camitine, (125I)T3 and (125I)T4 whole-cell uptake was inhibited by approximately 20% in fibroblasts and in HepG2, but by approximately 5% in NB 41A3 cells. Inhibition of T3 nuclear uptake was evaluated in HepG2 and NB 41A3 cells. At 10 mM carnitine, inhibition of T3 nuclear uptake was disproportionately higher, namely approximately 25% in neurons and 35% in hepatocytes. At 50 mM carnitine, there was a minimal additional decrease in whole-cell uptake of either hormone but a marked decrease in T3 nuclear uptake. The latter inhibition was approximately 60% in neurons and 70% in hepatocytes. We are aware of no inhibitor of TH uptake that has such a markedly different effect on the nuclear versus whole-cell uptake. Our data are consistent with carnitine being a peripheral antagonist of TH action, and they indicate a site of inhibition at or before the nuclear envelope.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11201848     DOI: 10.1089/thy.2000.10.1043

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  Unexpected awakening from comatose thyroid storm after a single intravenous injection of L-carnitine.

Authors:  Antoine Kimmoun; Gaittha Munagamage; Nicolas Dessalles; Alain Gerard; François Feillet; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-07-08       Impact factor: 17.440

2.  Decreased anxiety- and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism.

Authors:  J Patrizia Stohn; M Elena Martinez; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2016-08-24       Impact factor: 4.905

3.  Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity.

Authors:  C Di Cosmo; G De Marco; P Agretti; E Ferrarini; A Dimida; P Falcetta; S Benvenga; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2021-11-30       Impact factor: 4.256

4.  Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease.

Authors:  Daiki Setoyama; Ho Yeop Lee; Ji Sun Moon; Jingwen Tian; Yea Eun Kang; Ju Hee Lee; Minho Shong; Dongchon Kang; Hyon-Seung Yi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-30       Impact factor: 12.910

5.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30

6.  Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies.

Authors:  Salvatore Benvenga; Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Armando Patrizio; Sabrina Rosaria Paparo; Stefania Camastra; Daniela Bonofiglio; Alessandro Antonelli; Poupak Fallahi
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

Review 7.  Nutraceutical Supplements in the Thyroid Setting: Health Benefits beyond Basic Nutrition.

Authors:  Salvatore Benvenga; Ulla Feldt-Rasmussen; Daniela Bonofiglio; Ernest Asamoah
Journal:  Nutrients       Date:  2019-09-13       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.